NLSPW
Closed
Nls Pharmaceutics Ag
0.019
-0.001 (-5.00%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 0.02
Day's Range: 0.019 - 0.0201
Send
sign up or login to leave a comment!
When Written:
0.18
NLS Pharmaceutics AG is a biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) diseases. The company's lead product candidate, Quilience, is a novel oral formulation of the non-opioid analgesic tramadol for the treatment of chronic pain. NLS Pharmaceutics also has a pipeline of other CNS-focused drug candidates in various stages of development, including treatments for Parkinson's disease, schizophrenia, and depression. The company is headquartered in Switzerland and has additional offices in Israel and the United States.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








